Decorin Antikörper (AA 122-150)

Produktnummer ABIN7870329

Der Kaninchen Polyklonal anti-Decorin Antikörper wird verwendet zum Nachweis von Decorin in Proben von Human und Maus. Er wurde validiert für WB, IHC (p) und FACS.

Kurzübersicht für Decorin Antikörper (AA 122-150) (ABIN7870329)

Target: Decorin (DCN)

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Decorin Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Produktdetails anti-Decorin Antikörper

Bindungsspezifität: AA 122-150

Verwendungszweck: DCN Antibody / Decorin

Aufreinigung: Purified

Immunogen: A portion of amino acids 122-150 from the human protein was used as the immunogen for the DCN antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: The stated application concentrations are suggested starting points. Titration of the DCN antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the DCN antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu Decorin

Target: Decorin (DCN)

Andere Bezeichnung: DCN

Hintergrund: DCN is a small cellular or pericellular matrix proteoglycan that is closely related in structure to biglycan protein. The protein and biglycan are thought to be the result of a gene duplication. This protein is a component of connective tissue, binds to type I collagen fibrils, and plays a role in matrix assembly. It contains one attached glycosaminoglycan chain. This protein is capable of suppressing the growth of various tumor cell lines.

UniProt: P07585

Pathways: Glycosaminoglycan Metabolic Process